Expression of arginase II in prostate cancer

Shannon M. Mumenthaler, Hong Yu, Sheila Tze, Stephen D. Cederbaum, Anthony Pegg, David B. Seligson, Wayne W. Grody

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Previous reports have shown elevated arginase activity in prostate cancer patients. This study was designed to compare expression levels of arginase II (AII) in various human prostate cancer cell lines and tissues. Expression levels of AII and other enzymes involved in arginine metabolism were examined in androgen-dependent (LNCaP, LAPC-4) and androgen-independent (PC3, DU145, CL-1, CL-2) prostate cancer cell lines by real-time RT-PCR and Western blot analysis. Further expression analysis of AII was accomplished by immunohistochemical staining of a tissue microarray comprised of 246 primary prostatectomy specimens. In addition, polyamine levels were measured within the prostate cancer cell lines by HPLC. Total polyamines were significantly lower in the androgen-dependent cell lines compared to the androgen-independent cell lines. AII expression was found to be most prominent in the androgen-dependent cell lines and least prominent in the androgen-independent cell lines. Additionally, we found expression of ornithine aminotransferase (OAT), an enzyme also responsible for omithine production, to be inversely correlated with AII expression. The tissue microarray data revealed that the highest AII expression was seen in BPH, followed by PIN and normal samples, with the lowest expression levels observed in prostate cancer tissues. Moreover, we observed an expression gradient across Gleason grades revealing stronger AII expression in low-grade tumors. The polyamine data, combined with the expression analysis studies, support a possible correlation between AII, OAT, and polyamine synthesis. Based on these results, arginase II expression may play a role in prostate cancer progression. More specifically, the elevated AII expression seen in androgen-dependent and in more differentiated prostate cancers suggests that AII could be a potentially useful marker of early stage prostate adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)357-365
Number of pages9
JournalInternational journal of oncology
Volume32
Issue number2
StatePublished - Feb 1 2008

Fingerprint

Arginase
Prostatic Neoplasms
Androgens
Cell Line
Polyamines
Ornithine-Oxo-Acid Transaminase
Enzymes
Prostatectomy
Arginine
Real-Time Polymerase Chain Reaction
Prostate
Adenocarcinoma

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Mumenthaler, S. M., Yu, H., Tze, S., Cederbaum, S. D., Pegg, A., Seligson, D. B., & Grody, W. W. (2008). Expression of arginase II in prostate cancer. International journal of oncology, 32(2), 357-365.
Mumenthaler, Shannon M. ; Yu, Hong ; Tze, Sheila ; Cederbaum, Stephen D. ; Pegg, Anthony ; Seligson, David B. ; Grody, Wayne W. / Expression of arginase II in prostate cancer. In: International journal of oncology. 2008 ; Vol. 32, No. 2. pp. 357-365.
@article{66c84d74535c4ea39e0c4b53b94b41e2,
title = "Expression of arginase II in prostate cancer",
abstract = "Previous reports have shown elevated arginase activity in prostate cancer patients. This study was designed to compare expression levels of arginase II (AII) in various human prostate cancer cell lines and tissues. Expression levels of AII and other enzymes involved in arginine metabolism were examined in androgen-dependent (LNCaP, LAPC-4) and androgen-independent (PC3, DU145, CL-1, CL-2) prostate cancer cell lines by real-time RT-PCR and Western blot analysis. Further expression analysis of AII was accomplished by immunohistochemical staining of a tissue microarray comprised of 246 primary prostatectomy specimens. In addition, polyamine levels were measured within the prostate cancer cell lines by HPLC. Total polyamines were significantly lower in the androgen-dependent cell lines compared to the androgen-independent cell lines. AII expression was found to be most prominent in the androgen-dependent cell lines and least prominent in the androgen-independent cell lines. Additionally, we found expression of ornithine aminotransferase (OAT), an enzyme also responsible for omithine production, to be inversely correlated with AII expression. The tissue microarray data revealed that the highest AII expression was seen in BPH, followed by PIN and normal samples, with the lowest expression levels observed in prostate cancer tissues. Moreover, we observed an expression gradient across Gleason grades revealing stronger AII expression in low-grade tumors. The polyamine data, combined with the expression analysis studies, support a possible correlation between AII, OAT, and polyamine synthesis. Based on these results, arginase II expression may play a role in prostate cancer progression. More specifically, the elevated AII expression seen in androgen-dependent and in more differentiated prostate cancers suggests that AII could be a potentially useful marker of early stage prostate adenocarcinoma.",
author = "Mumenthaler, {Shannon M.} and Hong Yu and Sheila Tze and Cederbaum, {Stephen D.} and Anthony Pegg and Seligson, {David B.} and Grody, {Wayne W.}",
year = "2008",
month = "2",
day = "1",
language = "English (US)",
volume = "32",
pages = "357--365",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

Mumenthaler, SM, Yu, H, Tze, S, Cederbaum, SD, Pegg, A, Seligson, DB & Grody, WW 2008, 'Expression of arginase II in prostate cancer', International journal of oncology, vol. 32, no. 2, pp. 357-365.

Expression of arginase II in prostate cancer. / Mumenthaler, Shannon M.; Yu, Hong; Tze, Sheila; Cederbaum, Stephen D.; Pegg, Anthony; Seligson, David B.; Grody, Wayne W.

In: International journal of oncology, Vol. 32, No. 2, 01.02.2008, p. 357-365.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of arginase II in prostate cancer

AU - Mumenthaler, Shannon M.

AU - Yu, Hong

AU - Tze, Sheila

AU - Cederbaum, Stephen D.

AU - Pegg, Anthony

AU - Seligson, David B.

AU - Grody, Wayne W.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Previous reports have shown elevated arginase activity in prostate cancer patients. This study was designed to compare expression levels of arginase II (AII) in various human prostate cancer cell lines and tissues. Expression levels of AII and other enzymes involved in arginine metabolism were examined in androgen-dependent (LNCaP, LAPC-4) and androgen-independent (PC3, DU145, CL-1, CL-2) prostate cancer cell lines by real-time RT-PCR and Western blot analysis. Further expression analysis of AII was accomplished by immunohistochemical staining of a tissue microarray comprised of 246 primary prostatectomy specimens. In addition, polyamine levels were measured within the prostate cancer cell lines by HPLC. Total polyamines were significantly lower in the androgen-dependent cell lines compared to the androgen-independent cell lines. AII expression was found to be most prominent in the androgen-dependent cell lines and least prominent in the androgen-independent cell lines. Additionally, we found expression of ornithine aminotransferase (OAT), an enzyme also responsible for omithine production, to be inversely correlated with AII expression. The tissue microarray data revealed that the highest AII expression was seen in BPH, followed by PIN and normal samples, with the lowest expression levels observed in prostate cancer tissues. Moreover, we observed an expression gradient across Gleason grades revealing stronger AII expression in low-grade tumors. The polyamine data, combined with the expression analysis studies, support a possible correlation between AII, OAT, and polyamine synthesis. Based on these results, arginase II expression may play a role in prostate cancer progression. More specifically, the elevated AII expression seen in androgen-dependent and in more differentiated prostate cancers suggests that AII could be a potentially useful marker of early stage prostate adenocarcinoma.

AB - Previous reports have shown elevated arginase activity in prostate cancer patients. This study was designed to compare expression levels of arginase II (AII) in various human prostate cancer cell lines and tissues. Expression levels of AII and other enzymes involved in arginine metabolism were examined in androgen-dependent (LNCaP, LAPC-4) and androgen-independent (PC3, DU145, CL-1, CL-2) prostate cancer cell lines by real-time RT-PCR and Western blot analysis. Further expression analysis of AII was accomplished by immunohistochemical staining of a tissue microarray comprised of 246 primary prostatectomy specimens. In addition, polyamine levels were measured within the prostate cancer cell lines by HPLC. Total polyamines were significantly lower in the androgen-dependent cell lines compared to the androgen-independent cell lines. AII expression was found to be most prominent in the androgen-dependent cell lines and least prominent in the androgen-independent cell lines. Additionally, we found expression of ornithine aminotransferase (OAT), an enzyme also responsible for omithine production, to be inversely correlated with AII expression. The tissue microarray data revealed that the highest AII expression was seen in BPH, followed by PIN and normal samples, with the lowest expression levels observed in prostate cancer tissues. Moreover, we observed an expression gradient across Gleason grades revealing stronger AII expression in low-grade tumors. The polyamine data, combined with the expression analysis studies, support a possible correlation between AII, OAT, and polyamine synthesis. Based on these results, arginase II expression may play a role in prostate cancer progression. More specifically, the elevated AII expression seen in androgen-dependent and in more differentiated prostate cancers suggests that AII could be a potentially useful marker of early stage prostate adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=38849098350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849098350&partnerID=8YFLogxK

M3 - Article

C2 - 18202758

AN - SCOPUS:38849098350

VL - 32

SP - 357

EP - 365

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -

Mumenthaler SM, Yu H, Tze S, Cederbaum SD, Pegg A, Seligson DB et al. Expression of arginase II in prostate cancer. International journal of oncology. 2008 Feb 1;32(2):357-365.